Edition:
United Kingdom

People: Axsome Therapeutics Inc (AXSM.OQ)

AXSM.OQ on NASDAQ Stock Exchange Global Market

2.64USD
18 Dec 2018
Change (% chg)

-- (--)
Prev Close
$2.64
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
39,148
52-wk High
$5.90
52-wk Low
$2.05

Pizzie, Nick 

Mr. Nick Pizzie is appointed as Chief Financial Officer of the company effective May 16, 2018. He was the Vice President and Chief Financial Officer of Pierre Fabre USA, the U.S. affiliate of Pierre Fabre, prior to joining the Company. Previously, he was Senior Finance Director at Immucor. Prior to Immucor, he held positions of increasing responsibility in finance and accounting at Merck and Pfizer. Mr. Pizzie began his career at Arthur Andersen, where he served as staff auditor. He earned his BS in Accounting, BA in Economics, and MBA in Finance, and Supply Side Logistics, from Rutgers University.

Basic Compensation

Total Annual Compensation, --
Restricted Stock Award, --
Long-Term Incentive Plans, --
All Other, --
Fiscal Year Total, --

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --